Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
University of Utah Health
Although the formulation demonstrated favorable physicochemical characteristics for topical use, the relatively wide particle size distribution could impact batch-to-batch reproducibility and biological efficacy
doi: 10.1016/j.cgh.2024.02.022, 25
Ann Surg
Mazor D, Golan E, Philip V, Katz M, Jafe A, et al
For instance, on January 3, 2024, Glenmark Pharmaceuticals Ltd., an Indian multinational pharmaceutical company, announced that it had launched a biosimilar of the anti-diabetic drug, Liraglutide, in India
US$ 25.34
US$ 29.35
US$ 25.35
US$ 24.55
